Compare

GeneDx Holdings Corp. vs Omada Health, Inc. vs U S Physical Therapy Inc vs Pennant Group, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearGeneDx Holdings Corp.
WGS
Omada Health, Inc.
OMDA
U S Physical Therapy Inc
USPH
Pennant Group, Inc.
PNTG
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$427.54M$260.21M$780.99M$947.71M
Revenue growth (YoY)+40.0%+53.2%+16.3%+36.3%
Gross margin69.7%65.7%19.2%n/a
Operating margin-3.1%-4.6%11.1%5.5%
Net margin-4.9%-4.9%5.1%3.1%
Net income-$21.02M-$12.78M$39.58M$29.58M
EPS (Diluted)-$0.73-$0.35$1.42$0.84
Operating cash flow$33.28M$18.25M$75.06M$48.29M
Free cash flow$14.26M$16.93M$60.99M$36.26M
Cash & equivalents$105.00M$222.04M$35.57Mn/a
Total assets$523.71M$305.41M$1.20B$968.18M
Total liabilities$215.53M$75.73M$433.81M$593.93M
Shareholders' equity$308.18M$229.68M$476.89M$374.25M
Return on year-end equity-6.8%-5.6%8.3%7.9%
Shares outstanding29.25M58.43Mn/a34.63M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearGeneDx Holdings Corp.Omada Health, Inc.U S Physical Therapy IncPennant Group, Inc.
Latest$427.54M
Ended 2025-12-31
$260.21M
Ended 2025-12-31
$780.99M
Ended 2025-12-31
$947.71M
Ended 2025-12-31
1 year earlier$305.45M
Ended 2024-12-31
$169.80M
Ended 2024-12-31
$671.35M
Ended 2024-12-31
$695.24M
Ended 2024-12-31
2 years earlier$202.57M
Ended 2023-12-31
$122.78M
Ended 2023-12-31
$604.80M
Ended 2023-12-31
$544.89M
Ended 2023-12-31
3 years earlier$234.69M
Ended 2022-12-31
n/a$553.14M
Ended 2022-12-31
$473.24M
Ended 2022-12-31
4 years earlier$212.19M
Ended 2021-12-31
n/a$495.02M
Ended 2021-12-31
$439.69M
Ended 2021-12-31